ALEXANDRIA, Va., July 25, 2013 /PRNewswire-USNewswire/ --National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA issued the following statement today regarding S. 959, legislation that is expected to be considered soon in the full U.S. Senate:(Logo:http://photos.prnewswire.com/prnh/20100106/DC33253LOGO)"This legislation is comprised of two major components impacting independent community pharmacies and their patients."First, S. 959 seeks to enhance the security of the U.S. pharmaceutical supply chain by adopting national standards and policies, sometimes referred to as 'track-and-trace,' in place of a patchwork of conflicting state laws. NCPA appreciates the sensitivity of Senate and House lawmakers to try and avoid potentially burdensome legislative requirements that may uniquely impact small business community pharmacies, compared to national corporations with large compliance departments. NCPA has worked tirelessly to balance supply chain safety without adding onerous requirements on small business pharmacies. Federal track-and-trace legislation must achieve a common-sense balance between the need for enhanced patient safety and minimizing unreasonable burdens on supply chain stakeholders.
continue to read here
continue to read here
No comments:
Post a Comment